Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
PREVDUO vs DEHYDRATED ALCOHOL
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: July 2026 · OpiCalc Medical Review Team
Prevduo (doxycycline hyclate and omadacycline) is a combination of two tetracycline antibiotics. Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-t RNA from binding to the m RNA-ribosome complex. Omadacycline, a aminomethylcycline, also binds to the 30S subunit but overcomes common tetracycline resistance mechanisms (e.g., efflux pumps, ribosomal protection proteins).
Dehydrated alcohol (ethanol) causes tissue necrosis by protein denaturation and cellular dehydration, leading to vascular thrombosis and ischemic infarction. It ablates nerve tissue by extracting lipids and precipitating proteins.
Acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible pathogens,Community-acquired bacterial pneumonia (CABP),Uncomplicated skin and soft tissue infections (off-label),Acne vulgaris (off-label)
FDA-approved for adjunctive therapy in the treatment of cystic thyroid nodules,Off-label: Neurolysis for celiac plexus block in pancreatic cancer pain,Off-label: Ablation of hepatocellular carcinoma,Off-label: Sclerotherapy for esophageal varices
Adults: 1 tablet (500 mg sulfamethoxazole/80 mg trimethoprim) orally every 12 hours for 14 days.
Intravenous administration: 0.1-1 m L of sterile dehydrated alcohol (100% ethanol) injected directly into cystic lesions or tumors under imaging guidance. Maximum volume per injection: 1 m L, repeated up to 3 times per session depending on lesion size.
Terminal half-life 9-12 hours (prolonged in renal impairment, clinical monitoring recommended)
2-4 hours in most individuals at zero-order kinetics; terminal half-life is concentration-dependent due to saturation of alcohol dehydrogenase. Clinically, elimination rate is constant at 15-20 mg/d L/hour in non-tolerant individuals.
Doxycycline is partially metabolized in the liver via glucuronidation and other pathways; excreted in feces and urine. Omadacycline is not significantly metabolized; primarily eliminated unchanged in feces and urine.
Primarily hepatic via alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH); minor metabolism via CYP2E1 at high concentrations.
Renal: 70% unchanged; fecal: 20% (biliary); 10% metabolized
Ethanol is primarily eliminated by hepatic metabolism (90-98%) via alcohol dehydrogenase and aldehyde dehydrogenase, with 2-10% excreted unchanged in urine, breath, and sweat. Renal elimination is minor and variable.
85-90% bound to albumin and alpha-1-acid glycoprotein
Negligible (<5%); no specific binding proteins.
1.5 L/kg (extensive distribution; suggests high tissue penetration)
0.5-0.7 L/kg, approximating total body water. Higher in females due to lower lean body mass.
Oral: 60-70% (first-pass metabolism; food reduces absorption by 20%)
Oral: ~80-100% due to rapid absorption from stomach and small intestine; IV: 100%.
Cr Cl 15-30 m L/min: 50% of standard dose every 12 hours. Cr Cl <15 m L/min: not recommended.
No dosage adjustment required for renal impairment.
Child-Pugh Class A: no adjustment needed. Child-Pugh Class B or C: contraindicated.
No specific Child-Pugh-based adjustments; use with caution in severe hepatic dysfunction due to potential accumulation.
Children: 8 mg/kg/day trimethoprim and 40 mg/kg/day sulfamethoxazole divided every 12 hours. Maximum duration 14 days.
Not recommended for use in pediatric patients due to lack of safety and efficacy data.
Monitor renal function; reduce dose if Cr Cl <30 m L/min; avoid in elderly with folate deficiency.
No specific dose adjustment; use with caution due to age-related comorbidities and potential for increased sensitivity.
No FDA black box warnings are listed for Prevduo.
No FDA boxed warning exists for dehydrated alcohol. However, it should only be administered by physicians experienced in injection techniques for specific indications due to risk of tissue necrosis and nerve damage.
May cause tooth discoloration and enamel hypoplasia if used during tooth development (children <8 years),May cause photosensitivity; avoid excessive sunlight or UV exposure,Use caution in patients with hepatic impairment,May result in overgrowth of non-susceptible organisms including Clostridioides difficile,Potential for decreased efficacy with concomitant use of antacids, iron, or multivitamins,May cause dizziness or lightheadedness; caution when driving or operating machinery
Risk of tissue necrosis and sloughing if extravasation occurs,Neurological injury if injected near nerves (e.g., peripheral nerve damage, paralysis),Hypotension and bradycardia during celiac plexus block,Alcohol intoxication and CNS depression if absorbed systemically,Use with caution in patients with liver disease or diabetes mellitus
Hypersensitivity to doxycycline, omadacycline, or any tetracycline,Pregnancy (may cause fetal harm based on animal data),Lactation (potential for serious adverse reactions in nursing infants)
Hypersensitivity to ethanol or any component of the formulation,Acute infection at the injection site,Uncorrectable coagulation abnormalities,Pregnancy (relative contraindication due to fetal alcohol spectrum disorders)
Avoid grapefruit and grapefruit juice during treatment. No significant food interactions otherwise.
No specific food interactions. However, avoid alcohol consumption for 24 hours post-procedure due to risk of additive CNS depression.
Pregnancy Category X. First trimester: high risk of skeletal and cardiac malformations (neural tube defects, cleft palate). Second and third trimesters: oligohydramnios, renal agenesis, pulmonary hypoplasia, intracranial hemorrhage, and fetal death.
First trimester: Data limited; alcohol is a known teratogen causing fetal alcohol spectrum disorders. Increased risk of congenital anomalies (e.g., heart defects, microcephaly) with high systemic exposure. Second trimester: Continued risk for growth restriction and neurodevelopmental abnormalities. Third trimester: Risk of growth retardation, preterm birth, and neurobehavioral deficits. Avoid systemic use; local injection for nerve block or ablation has minimal systemic absorption but caution advised.
Contraindicated due to risk of neonatal hypotension, nephrotoxicity, and cardiac arrest. M/P ratio not determined; likely excreted in breast milk.
Alcohol is excreted into breast milk; M/P ratio approximately 1.0. Chronic ingestion can impair infant motor development. Dehydrated alcohol for therapeutic injection likely results in negligible systemic levels; however, avoid breastfeeding immediately after procedure. Advise discarding milk for 2-3 hours post-procedure.
No dose adjustments possible due to teratogenicity; drug is contraindicated throughout pregnancy. If inadvertently used, immediate discontinuation and specialist consultation required.
No dose adjustment needed for localized injection; pharmacokinetics of ethanol unchanged in pregnancy. Avoid use as systemic agent; use alternative if possible.
PREVDUO (budesonide/glycopyrrolate/formoterol fumarate) is a fixed-dose triple therapy for COPD. Administer as two inhalations twice daily. No rescue use. Titrate to lowest effective dose. Monitor for pneumonia, oral candidiasis, and hypercortisolism. Use with caution in patients with severe hepatic impairment. Assess cardiovascular risk due to formoterol.
Absolute ethanol (dehydrated alcohol) is used for neurolysis in celiac plexus block for pancreatic cancer pain and for ablation of certain soft tissue lesions. Administer slowly to avoid local toxicity. Inadvertent intravascular injection can cause immediate pain and tissue necrosis. Use ultrasound or CT guidance for accurate placement. Monitor for hypotension, pain, and transient alcohol intoxication. Contraindicated in patients with bleeding disorders or local infection.
Use exactly as prescribed; do not use for sudden symptoms.,Rinse mouth with water after each dose to prevent thrush.,Avoid exceeding two inhalations twice daily.,Report worsening symptoms or need for increased rescue inhaler use.,Notify healthcare provider of any vision changes, signs of infection, or adrenal insufficiency.
You may feel a temporary burning sensation at the injection site.,This medication is used to block pain signals from certain nerves.,Avoid alcohol consumption for 24 hours after the procedure to prevent additive effects.,Report any severe pain, bleeding, or signs of infection to your healthcare provider.,You may experience temporary dizziness or lightheadedness after the injection.
No interactions on record
No interactions on record
Explore head-to-head clinical comparisons of other medications in the same therapeutic classes.
Common clinical questions about PREVDUO vs DEHYDRATED ALCOHOL, answered by our medical review team.
PREVDUO is a Topical Antiseptic that works by Prevduo (doxycycline hyclate and omadacycline) is a combination of two tetracycline antibiotics. Doxycycline inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-t RNA from binding to the m RNA-ribosome complex. Omadacycline, a aminomethylcycline, also binds to the 30S subunit but overcomes common tetracycline resistance mechanisms (e.g., efflux pumps, ribosomal protection proteins).. DEHYDRATED ALCOHOL is a Sclerosing agent that works by Dehydrated alcohol (ethanol) causes tissue necrosis by protein denaturation and cellular dehydration, leading to vascular thrombosis and ischemic infarction. It ablates nerve tissue by extracting lipids and precipitating proteins.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between PREVDUO and DEHYDRATED ALCOHOL depend on the specific clinical indication. These are agents from distinct pharmacological classes and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of PREVDUO is: Adults: 1 tablet (500 mg sulfamethoxazole/80 mg trimethoprim) orally every 12 hours for 14 days.. The standard adult dose of DEHYDRATED ALCOHOL is: Intravenous administration: 0.1-1 m L of sterile dehydrated alcohol (100% ethanol) injected directly into cystic lesions or tumors under imaging guidance. Maximum volume per injection: 1 m L, repeated up to 3 times per session depending on lesion size.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between PREVDUO and DEHYDRATED ALCOHOL in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. PREVDUO is classified as Category C. Pregnancy Category X. First trimester: high risk of skeletal and cardiac malformations (neural tube defects, cleft palate). Second and third trimesters: oligohydramnios, renal agen. DEHYDRATED ALCOHOL is classified as Category C. First trimester: Data limited; alcohol is a known teratogen causing fetal alcohol spectrum disorders. Increased risk of congenital anomalies (e.g., heart defects, microcephaly) wit. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.